Sunil Healthcare Limited
BSE: SUNLOC
Prev Close
76.69
Open Price
76.5
Volume
410
Today Low / High
76.5 / 77.27
52 WK Low / High
60.55 / 87.9
Range
73 - 80
The stock is currently available for trading on the Bombay Stock Exchange (BSE). Its price is 76.5, reflecting a change of -0.19 (-0.24775%). The expected target range on the BSE is 73 - 80. The stock is showing a downward trend on the BSE. This could indicate a potential risk for investors who are considering buying at this moment.
Sunil Healthcare Limited Graph
Sunil Healthcare Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Sunil Healthcare Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 76.50, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 76.50 | 77.27 | 69.54 - 84.99 |
| 78.03 | 62.42 - 93.64 | ||
| 78.80 | 55.16 - 102.43 | ||
| Bearish Scenario | 76.50 | 75.74 | 68.16 - 83.31 |
| 74.97 | 59.98 - 89.96 | ||
| 74.21 | 51.94 - 96.47 |
Overview of Sunil Healthcare Limited
ISIN
INE671C01016
Industry
Medical - Pharmaceuticals
Vol.Avg
1,172
Market Cap
840,987,947
Last Dividend
0
Official Website
IPO Date
DCF Diff
171.18
DCF
-84
Financial Ratios Every Investor Needs
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 83.42 Cr | 54.82 Cr | 28.60 Cr | 0.3429 | 0.00 Cr | 0.00 Cr | 3.91 Cr | -1.42 Cr | -1.39 | 11.60 Cr | -0.0170 |
| 2024-03-31 | 90.16 Cr | 50.10 Cr | 40.06 Cr | 0.4444 | 0.00 Cr | 1.66 Cr | -1.22 Cr | -1.79 Cr | -1.74 | 9.31 Cr | -0.0198 |
| 2023-03-31 | 110.46 Cr | 51.10 Cr | 59.36 Cr | 0.5374 | 0.00 Cr | 2.41 Cr | 12.24 Cr | 6.68 Cr | 6.52 | 20.66 Cr | 0.0605 |
| 2022-03-31 | 119.16 Cr | 53.11 Cr | 66.05 Cr | 0.5543 | 0.00 Cr | 2.39 Cr | 16.46 Cr | 6.42 Cr | 6.26 | 18.13 Cr | 0.0539 |
| 2021-03-31 | 90.33 Cr | 46.54 Cr | 43.79 Cr | 0.4848 | 0.00 Cr | 2.00 Cr | 4.66 Cr | -0.64 Cr | -0.62 | 10.06 Cr | -0.0071 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.09 Cr | 161.94 Cr | 94.88 Cr | 67.0662 Cr | 68.64 Cr | 65.56 Cr | 17.64 Cr | 94.13 Cr | 0.00 Cr | 0.00 Cr | 1.50 Cr | 62.6018 Cr |
| 2024-03-31 | 0.08 Cr | 158.50 Cr | 90.28 Cr | 68.2168 Cr | 66.15 Cr | 66.07 Cr | 14.05 Cr | 93.22 Cr | 0.60 Cr | 0.00 Cr | -1.40 Cr | 57.3006 Cr |
| 2023-03-31 | 0.59 Cr | 120.79 Cr | 64.79 Cr | 55.9969 Cr | 35.63 Cr | 35.05 Cr | 13.60 Cr | 70.38 Cr | 0.11 Cr | 1.16 Cr | 2.27 Cr | 45.4846 Cr |
| 2022-03-31 | 0.27 Cr | 109.69 Cr | 59.74 Cr | 49.9549 Cr | 34.68 Cr | 34.42 Cr | 11.05 Cr | 71.55 Cr | 4.28 Cr | 0.00 Cr | 1.03 Cr | 39.8115 Cr |
| 2021-03-31 | 0.55 Cr | 120.56 Cr | 76.85 Cr | 43.7173 Cr | 48.95 Cr | 48.40 Cr | 13.73 Cr | 69.61 Cr | 3.87 Cr | 0.87 Cr | -0.93 Cr | 53.5132 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 5.5822 Cr | -7.9964 Cr | 2.3660 Cr | -3.8484 Cr | 0.0000 Cr | 3.0854 Cr | -9.4306 Cr | -1.4166 Cr | 2.3660 Cr | 0.0000 Cr | -3.5903 Cr |
| 2024-03-31 | -15.3965 Cr | -10.1144 Cr | 25.0031 Cr | -25.8618 Cr | -0.5078 Cr | 0.0789 Cr | -10.4653 Cr | -2.5551 Cr | 30.7606 Cr | 0.0000 Cr | -0.4499 Cr |
| 2023-03-31 | 7.4677 Cr | -3.4016 Cr | -3.7454 Cr | 3.2669 Cr | 0.3207 Cr | 0.5867 Cr | -4.2008 Cr | 9.4833 Cr | 0.7837 Cr | 0.0000 Cr | -2.5494 Cr |
| 2022-03-31 | 22.5132 Cr | -4.2396 Cr | -18.5596 Cr | 13.4731 Cr | -0.2860 Cr | 0.2660 Cr | -9.0401 Cr | 9.2647 Cr | -15.0352 Cr | 0.0000 Cr | 2.6739 Cr |
| 2021-03-31 | 16.9850 Cr | -11.3565 Cr | -6.4170 Cr | 10.1443 Cr | -0.7885 Cr | 0.5520 Cr | -6.8407 Cr | -0.5532 Cr | -0.2539 Cr | 0.0000 Cr | 11.1298 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 21.20 Cr | 13.89 Cr | 7.31 Cr | 0.3448 | 1.35 Cr | 0.36 Cr | 0.36 | 3.52 Cr | 0.0171 |
| 2024-12-31 | 20.46 Cr | 8.48 Cr | 11.98 Cr | 0.5854 | 1.02 Cr | -0.54 Cr | -0.53 | 3.23 Cr | -0.0264 |
| 2024-09-30 | 20.26 Cr | 8.89 Cr | 11.37 Cr | 0.5612 | 0.81 Cr | -0.55 Cr | -0.53 | 2.49 Cr | -0.0271 |
| 2024-06-30 | 21.50 Cr | 14.57 Cr | 6.93 Cr | 0.3224 | 0.73 Cr | -0.69 Cr | -0.67 | 2.35 Cr | -0.0322 |
| 2024-03-31 | 21.31 Cr | 12.84 Cr | 8.47 Cr | 0.3976 | 2.02 Cr | 0.15 Cr | 0.15 | 3.36 Cr | 0.0071 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 3.09 Cr | 0.00 Cr | 3.09 Cr | 41.64 Cr | 17.64 Cr | 65.11 Cr | 94.13 Cr | 161.94 Cr | 94.88 Cr |
| 2024-12-31 | 0.00 Cr | 0.00 Cr | 3.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -67.50 Cr |
| 2024-09-30 | 0.21 Cr | 3.15 Cr | 3.36 Cr | 0.00 Cr | 14.62 Cr | 61.29 Cr | 95.45 Cr | 158.86 Cr | 91.36 Cr |
| 2024-06-30 | 0.00 Cr | 0.00 Cr | 3.61 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -68.22 Cr |
| 2024-03-31 | 0.08 Cr | 3.53 Cr | 3.61 Cr | 41.77 Cr | 14.05 Cr | 62.49 Cr | 93.22 Cr | 158.50 Cr | 90.28 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2024-12-31 | -0.54 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | -0.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | -0.69 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-03-31 | 0.15 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2023-12-31 | -0.20 Cr | 2.91 Cr | 0.00 Cr | 0.00 Cr | 2.91 Cr | 2.94 Cr | 0.04 Cr | 0.00 Cr | 2.91 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Medical - Pharmaceuticals
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| MedPlus Health Services Limited | MEDPLUS | ₹804.05 | ₹96,279,696,851.00 | ₹756,659.00 |
Key Executives
Gender: male
Year Born: 1974
Gender: male
Year Born:
Gender: male
Year Born: 1973
Gender: male
Year Born: 1987
Gender: male
Year Born: 1956
Gender: male
Year Born: 1962
Gender: male
Year Born: 1991
Gender: female
Year Born: 1957
FAQs about Sunil Healthcare Limited
The CEO is Anil Kumar Khaitan.
The current price is ₹82.01.
The range is ₹60.55-87.9.
The market capitalization is ₹84.10 crores.
The P/E ratio is -59.55.
The company operates in the Healthcare sector.
Overview of Sunil Healthcare Limited (ISIN: INE671C01016) is a leading Medical - Pharmaceuticals in India. With a market capitalization of ₹84.10 crores and an average daily volume of 1,172 shares, it operates in the Medical - Pharmaceuticals. The company last declared a dividend of ₹0.